MEDICINOVA, INC. (MNOV)

1.63USD +0.62% (+0.01)

Over 1M: +21.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

1.3 1.4 1.5 1.6
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Income: -3.4M Q3 '25 — Free Cash Flow: -1.7M Q3 '25 — Net Income: -3.1M Q4 '25 — Operating Income: -3.1M Q4 '25 — Free Cash Flow: -2M Q4 '25 — Net Income: -2.8M Q1 '26 — Operating Income: -2.8M Q1 '26 — Free Cash Flow: -3.5M Q1 '26 — Net Income: -2.6M Q2 '26 — Operating Income: -2.5M Q2 '26 — Free Cash Flow: -1.9M Q2 '26 — Net Income: -2.3M -2.8M -2.1M -1.4M -700K 0
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Operating Income Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 100.3%
OE margin -1091.5%
Oper. margin -1287.4%
Accruals -4.1%
Asset turnover 0.023×
EBITDA margin -1285.3%
FCF margin -991.2%
OCF margin -989.7%
Profit margin -1168.2%
ROA -26.6%
ROCE -31.6%
ROE -28.9%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

2.1
EV/Sales 16.1×
EV/OE -1.5×
P/C 1.2×
P/B 2.2×
FCF yield -11.4%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 2.0×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.6
ND/EBITDA 4.4
Cash runway 7.2 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 8.8×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.4
Sales Q/Q +240.6%
Shares change +0.035%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales/sh Y/Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.